Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00527332Phase 4Completed
A Phase 4 trial of bupivacaine hydrochloride 0.75% injection, morphine in benign gynecological disease. Started Mar 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00527332.